_(3).png)
_(4).png){kind=logo}
Loading Shopping Cart Items...
FREE FOR MEMBERS!
Description: History has recorded antibiotics as wonder drugs. These therapies, however, are uniquely susceptible to obsolescence through the inexorable development of drug-resistant microbes. Today, drug-resistant infections threaten sustainability of healthcare systems and the productivity of the global economy. Innovation efforts have not kept up with the growing danger of drug-resistant infections. Modern industrial drug discovery programs have failed to yield any truly new antibiotics for more than 30 years. There is a pressing need to reinvigorate the field of antibacterial research by re-imagining the way in which antibiotics are discovered, developed and commercialized in order to ward off a post-antibiotic era.
Start date: Upon registration
Completion: Up to 52 weeks
At the end of this webinar you will be able to:
Speaker: Eric Brown, PhD
Dr. Eric Brown is a Distinguished University Professor in the Department of Biochemistry and Biomedical Sciences and member of the M.G. DeGroote Institute for Infectious Disease Research at McMaster University. Brown is a Fellow of the American Academy of Microbiology and has received a number of other awards including the Canadian Society of Microbiologists Murray Award for career achievement. He currently holds a Killam Research Fellowship from the Canada Council for the Arts and a Canada Research Chair in Microbial Chemical Biology. Brown’s research aims to probe the complex biology that underlies bacterial survival strategies. The goal of these studies is to contribute to fresh directions for new antibacterial therapies.
Recorded: October 27, 2021
PEP hours: 1.0
CPS credits: 0
*Note: PEP hours and/or CPS credits will only be awarded upon successful completion of the quiz.
Loading Shopping Cart Items...